SUBSCRIBE
SUBSCRIBE

Johnson & Johnson Family of Companies

NEWS
Policy
Biopharma Update on the Novel Coronavirus: May 1
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 1, 2020.
May 1, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: April 29
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 29, 2020.
April 29, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: April 28
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 28, 2020.
April 28, 2020
 · 
6 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: April 24
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 24, 2020.
April 24, 2020
 · 
7 min read
 · 
BioSpace Editorial Staff
Business
J&J and Emergent BioSolutions Strike Manufacturing Deal for COVID-19 Vaccine Candidate
Less than one month after Johnson & Johnson identified a lead vaccine candidate against COVID-19, the life sciences giant announced an agreement with Emergent BioSolutions to support the manufacturing needs for the potential medication.
April 24, 2020
 · 
2 min read
 · 
Alex Keown
Biotech Bay
GlobalData Report: Top 20 Pharma Companies Lost $2.6 Trillion Market Cap in Q1
The COVID-19 pandemic is having a devastating effect on global business and biopharma companies are not excluded.
April 23, 2020
 · 
3 min read
 · 
Mark Terry
Chronic lymphocytic leukemia
FDA
Imbruvica-Rituximab Combo Approved by FDA for Chronic Lymphocytic Leukemia
The FDA recently approved the combination of Imbruvica-Rituximab for treating chronic lymphocytic leukemia. Here’s everything you need to know.
April 22, 2020
 · 
2 min read
 · 
Mark Terry
Drug Development
Biopharma Update on the Novel Coronavirus: April 14
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 14, 2020.
April 14, 2020
 · 
6 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: April 8
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 8, 2020.
April 8, 2020
 · 
7 min read
 · 
BioSpace Editorial Staff
Load More
AWARDS
  • 2024 Best Places to Work
  • 2023 Best Places to Work
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Panther Medical Canada Inc. Opens in Canada Bringing State of the Art, Clinically Proven, Economically Viable Laparoscopic Surgical Solutions, while Saving Tax Payers Millions in Health Care Costs
July 18, 2018
 · 
3 min read
Business
Johnson & Johnson Innovation Announces JPOD @ Philadelphia to Accelerate Healthcare Innovation in Philadelphia’s Ecosystem
July 18, 2018
 · 
4 min read
FDA
Janssen Announces U.S. FDA Approval of SYMTUZA™ (D/C/F/TAF), the First and Only Complete Darunavir-Based Single-Tablet Regimen for the Treatment of HIV-1 Infection
July 17, 2018
 · 
13 min read
Business
Johnson & Johnson Reports 2018 Second-Quarter Results
July 17, 2018
 · 
111 min read
Deals
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2018
July 16, 2018
 · 
1 min read
Policy
Johnson & Johnson’s Official Statement in Response to Today’s Verdict in St. Louis Trial
July 12, 2018
 · 
1 min read
BioMidwest
Mercy Collaborates with Johnson & Johnson Medical Devices Companies to Harness Real-World Data for Patient Safety and Device Innovation
July 2, 2018
 · 
1 min read
Business
Saladax Signs Licensing Agreement with Janssen for Antipsychotic Drug Testing Patents
June 26, 2018
 · 
3 min read
Business
Johnson & Johnson to Host Investor Conference Call on 2018 Second-Quarter Results
June 19, 2018
 · 
1 min read
Deals
Johnson & Johnson Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan, Inc.
June 12, 2018
 · 
3 min read
Load More